Over 1 million Americans are affected with venous thromboembolism leading to loss of life and illness. Patients with cancer who receive chemotherapy are at an increased risk for developing fatal blood clots. Various earlier studies have also reported that preventive use of the blood-thinning medication can reduce these events.